Vaccine priority list must be refined to match available doses: Tam
OTTAWA — Canada’s chief public health officer says the priority list of people who will get vaccinated first against COVID-19 has to be refined because the initial six million doses set to arrive in the first batch will not be enough to cover them all.
Health Canada is in the final stages of reviewing the COVID-19 vaccines from Pfizer and Moderna. The regulator anticipates decisions on approving both before the end of December.
Vaccines from AstraZeneca and Johnson & Johnson are also being studied, with no suggestion yet of when those reviews might be done. Canada has contracts for three more vaccines in late-stage clinical trials but has not starting rolling reviews on any of them yet.
Dr. Theresa Tam said the variety of vaccines on Canada’s docket and the expectation that several will eventually be approved “means we will have more flexibility as time goes on, and more and more vaccines come on board.”


